Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microorganism cellular components is a broad, collective term referring to the diverse structural and functional elements found in bacteria, fungi, viruses, and parasites that serve as the primary targets for antimicrobial therapies. This category encompasses vital components such as the bacterial cell wall (peptidoglycan), fungal cell membranes (ergosterol), microbial ribosomes (30S and 50S subunits), and essential enzymes like DNA gyrase or RNA polymerase. These components are critical for the survival, replication, and pathogenesis of the microorganism. Antimicrobial drugs are designed to exploit the biochemical differences between these microbial components and human cellular structures to achieve selective toxicity. For example, beta-lactam antibiotics target the synthesis of the peptidoglycan layer, which is unique to bacteria, while macrolides bind to the bacterial ribosome to arrest protein synthesis. Because this term represents an entire class of heterogeneous targets rather than a single molecular entity, it is primarily used in high-level therapeutic classifications. Understanding these components is essential for addressing the mechanisms of drug action and the evolving challenge of antimicrobial resistance in clinical settings.
Inhibition of cell wall synthesis, disruption of protein synthesis (ribosomal inhibition), interference with nucleic acid replication, disruption of cell membrane permeability, and metabolic enzyme inhibition.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microorganism cellular components.